Latest update about MED-EL’s TICI:

MED=EL release details

---

MED-EL have just announced a major milestone in the treatment of hearing loss: the publication of a promising feasibility study on MED-EL's Totally Implantable Cochlear Implant (TICI).  

“One recurring wish we hear from patients in our daily clinical practice is that the implants should be as discreet as possible – or ideally invisible. Social stigma remains a challenge for many people with hearing impairments and can be a heavy burden in many situations", stated Prof Dr. Müller, Head of the Cochlear Implants and Hearing Prosthetics Section, Department of Otorhinolaryngology, Head & Neck Surgery at the University of Munich.

The TICI redefines hearing by integrating all components – audio processor, microphone, and battery – into one device that is fitted under the skin. This innovation offers users continuous hearing during daily activities, including sleep and bathing, without reliance on external parts. 
 
The study evaluated the safety and performance of the TICI in six participants with bilateral severe-to-profound hearing loss. The results demonstrated that the TICI delivers hearing performance comparable to conventional cochlear implants.  
 
The study not only provides evidence of the safety and initial clinical performance of the TICI but also highlights MED-EL's commitment to patient-centred care and innovation. 

Please click here for the full Press release.